silver sulfadiazine 10 MG/ML Topical Cream [Silvadene]
silver sulfadiazine
RxCUI: 208186
What the CMS Formulary Data Shows for silver sulfadiazine 10 MG/ML Topical Cream [Silvadene]
Per the CMS 2026 Part D formulary file, silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] (RxNorm concept RXCUI 208186, generic name silver sulfadiazine) appears on 2 distinct formulary files spanning 3 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 251,600 Part D beneficiaries filled silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] in 2023, with total plan-and-beneficiary spending of $6,799,393 and an average per-beneficiary annual cost of $27.02. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 3
- Coverage rate
- 0.1%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 251,600
- Total spending
- $6,799,393
- Avg per beneficiary
- $27.02
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering silver sulfadiazine 10 MG/ML Topical Cream [Silvadene]
3 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| CalOptima Health OneCare Complete (HMO D-SNP) | ORANGE COUNTY HEALTH AUTHORITY | T1 | No | $0 | CA |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] covered by Medicare Part D?
Yes, silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] is covered by 3 Medicare Part D plans (0.1% of all Part D formularies).
What tier is silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] on Medicare Part D plans?
silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] require prior authorization?
0% of Part D formularies require prior authorization for silver sulfadiazine 10 MG/ML Topical Cream [Silvadene]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on silver sulfadiazine 10 MG/ML Topical Cream [Silvadene]?
In 2023, total Medicare Part D spending on silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] was $6,799,393, covering 251,600 beneficiaries. The average spend per beneficiary was $27.02.
Read our methodology - how this data is sourced, computed, and verified.